Literature DB >> 12498989

Coexistence and function of different neurotransmitter transporters in the plasma membrane of CNS neurons.

Luca Raiteri1, Maurizio Raiteri, Giambattista Bonanno.   

Abstract

Transporters able to recapture released neurotransmitters into neurons can no longer be considered as cell-specific neuronal markers. In fact, colocalization on one nerve terminal of transporters able to selectively recapture the released endogenously synthesized transmitter (homotransporters) and of transporters that can selectively take up transmitters/modulators originating from neighboring structures (heterotransporters) has been demonstrated to occur on several families of nerve terminals. Activation of heterotransporters often increases the release of the transmitter stored in the terminals on which the heterotransporters are localized. The release caused by heterotransporter activation takes place through multiple mechanisms including exocytosis, either dependent on external Ca(2+) or on Ca(2+) mobilized from intraterminal stores, and homotransporter reversal. Homocarrier-mediated release elicited by heterocarrier activation represents a clear case of transporter-transporter interaction. Although the functional significance of transporter coexpression on one nerve terminal remains to be established, it may in some instances reflect cotransmission. In other cases, heterotransporters may mediate modulation of basal transmitter release in addition to the modulation of the evoked release brought about by presynaptic heteroreceptors. Heterotransporters are also increasingly reported to exist on neuronal soma/dendrites. With the exception of EAAT4, the glutamate transporter/chloride channel situated on GABAergic Purkinje cells in the cerebellum, the functions of somatodendritic heterocarriers is not understood.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12498989     DOI: 10.1016/s0301-0082(02)00059-x

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  9 in total

1.  Presynaptic glycine receptors influence plasma membrane potential and glutamate release.

Authors:  Tatyana V Waseem; Sergei V Fedorovich
Journal:  Neurochem Res       Date:  2010-04-30       Impact factor: 3.996

2.  Activation of a glycine transporter on spinal cord neurons causes enhanced glutamate release in a mouse model of amyotrophic lateral sclerosis.

Authors:  Luca Raiteri; Egle Paolucci; Simona Prisco; Maurizio Raiteri; Giambattista Bonanno
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

3.  Stress and corticosterone increase the readily releasable pool of glutamate vesicles in synaptic terminals of prefrontal and frontal cortex.

Authors:  G Treccani; L Musazzi; C Perego; M Milanese; N Nava; T Bonifacino; J Lamanna; A Malgaroli; F Drago; G Racagni; J R Nyengaard; G Wegener; G Bonanno; M Popoli
Journal:  Mol Psychiatry       Date:  2014-02-18       Impact factor: 15.992

4.  Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus.

Authors:  Giambattista Bonanno; Roberto Giambelli; Luca Raiteri; Ettore Tiraboschi; Simona Zappettini; Laura Musazzi; Maurizio Raiteri; Giorgio Racagni; Maurizio Popoli
Journal:  J Neurosci       Date:  2005-03-30       Impact factor: 6.167

5.  Gamma-vinyl GABA increases nonvesicular release of GABA and glutamate in the nucleus accumbens in rats via action on anion channels and GABA transporters.

Authors:  Xiao-Qing Peng; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Psychopharmacology (Berl)       Date:  2009-12-22       Impact factor: 4.530

Review 6.  Mixed neurotransmission in the hippocampal mossy fibers.

Authors:  Agnieszka Münster-Wandowski; Gisela Gómez-Lira; Rafael Gutiérrez
Journal:  Front Cell Neurosci       Date:  2013-11-22       Impact factor: 5.505

7.  A pharmaco-metabolomics approach in a clinical trial of ALS: Identification of predictive markers of progression.

Authors:  Hélène Blasco; Franck Patin; Amandine Descat; Guillaume Garçon; Philippe Corcia; Patrick Gelé; Timothée Lenglet; Peter Bede; Vincent Meininger; David Devos; Jean François Gossens; Pierre-François Pradat
Journal:  PLoS One       Date:  2018-06-05       Impact factor: 3.240

8.  Revolutionary impact of nanodrug delivery on neuroscience.

Authors:  Reza Khanbabaie; Mohsen Jahanshahi
Journal:  Curr Neuropharmacol       Date:  2012-12       Impact factor: 7.363

9.  Chronic treatment with agomelatine or venlafaxine reduces depolarization-evoked glutamate release from hippocampal synaptosomes.

Authors:  Marco Milanese; Daniela Tardito; Laura Musazzi; Giulia Treccani; Alessandra Mallei; Tiziana Bonifacino; Cecilia Gabriel; Elisabeth Mocaer; Giorgio Racagni; Maurizio Popoli; Giambattista Bonanno
Journal:  BMC Neurosci       Date:  2013-07-29       Impact factor: 3.288

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.